InChI: | InChI=1/C16H11ClN2O3.2K.H2O/c17-10-6-7-12-11(8-10)13(9-4-2-1-3-5-9)19-14(16(21)22)15(20)18-12;;;/h1-8,14H,(H,18,20)(H,21,22);;;1H2/q;2*+1;/p-2/rC16H11ClN2O3.HKO.K/c17-10-6-7-12-11(8-10)13(9-4-2-1-3-5-9)19-14(16(21)22)15(20)18-12;1-2;/h1-8,14H,(H,18,20)(H,21,22);2H;/q;;+1/p-1 |
Specification: |
Clorazepate dipotassium with cas registry number of 57109-90-7 is also known as Clorazepate Dipotassium [USAN:JAN] ; 1H-1,4-Benzodiazepine-3-carboxylic acid, 7-chloro-2,3-dihydro-2-oxo-5-phenyl-, monopotassium salt, compd. with potassium hydroxide ; 1H-1,4-Benzodiazepine-3-carboxylic acid, 7-chloro-2,3-dihydro-2-oxo-5-phenyl-, monopotassium salt, compd. with potassium hydroxide (K(OH)) (1:1) ; 1H-1,4-Benzodiazepine-3-carboxylic acid, 7-chloro-2,3-dihydro-2-oxo-5-phenyl-, potassium salt compd. with potassium hydroxide (1:1) ; 1H-1,4-Benzodiazepine-3-carboxylic acid, 7-chloro-2,3-dihydro-2-oxo-5-phenyl-, potassium salt compound with potassium hydroxide (1:1) ; 4306 CB ; AB 35616 ; AH 3232 ; Abbott-35616 ; Belseren ; Bipotassium chlorazepate ; CB 4306 ; Clorazepate ; Chlorazepam ; Chlorazepate ; Clorazepate acid dipotassium salt ; Clorazepate dipotassique ; Clorazepate dipotassique [INN-French] ; Clorazepate dipotassium ; Clorazepato ; Clorazepato [DCIT] ; Clorazepato dipotasico ; Clorazepato dipotasico [INN-Spanish] ; DEA No. 2768 ; Dikalii clorazepas ; Dikalii clorazepas [INN-Latin] ; Dipotassium chlorazepate ; Dipotassium clorazepate ; Gen-Xene ; Mendon ; Modiur ; Nevracten ; Potassium 7-chloro-2,3-dihydro-2-oxo-5-phenyl-1H-1,4-benzodiazepine-3-carboxylate KOH ; Potassium 7-chloro-2,3-dihydro-2-oxo-5-phenyl-1H-1,4-benzodiazepine-3-carboxylate compound with potassium hydroxide (1:1) ; Softramal ; TR 19119 ; Tencilan ; Tranex ; Transilium ; Tranxene ; Tranxene SD ; Tranxilen ; Tranxilene ; Tranxilium ; UNII-63FN7G03XY .
|